Robert Grundstein
@Sabby Management, Llc
Latest period2024 - Q3ReportedManaged Assets$186.418MTotal holdings42
Assets growth rate-99.87%Assets growth rate (2-Q avg)-57.03%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Sabby Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 42 positions.
Assets under management
The assets under management (AUM) of Sabby Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 186.418M in assets, with a quarterly growth rate of -99.87% and a 2-quarter average growth rate of -57.03%. The portfolio is managed by Robert Grundstein, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
CORZWCore Scientific
| 0% | $762.073M 168,974 shares@ $4510.01 avg price | Exited |
RDHLRedhill Biopharma Ltd
| 0% | $497.179M 1.341M shares@ $370.71 avg price | Exited |
GWAVGreenwave Technology
| 0% | $406.165M 229,472 shares@ $1770.0 avg price | Exited |
ELTKEltek Ltd
| 0% | $395.509M 40,565 shares@ $9750.01 avg price | Exited |
IWMIshares Tr
| 0% | $304.335M 1,500 shares@ $202890.0 avg price | Exited |
RVPHReviva Pharmaceutcls Hldgs Inc
| 0% | $303.356M 236,997 shares@ $1280.0 avg price | Exited |
BIVIBiovie Inc
| 0% | $293.589M 733,055 shares@ $400.51 avg price | Exited |
LIPOLipella Pharmaceuticals Inc
| 0% | $243.113M 540,250 shares@ $450.01 avg price | Exited |
SONNSonnet Biotherapeutics Hldng Inc
| 0% | $223.495M 238,395 shares@ $937.5 avg price | Exited |
APVOAptevo Therapeutics Inc
| 0% | $153.459M 501,499 shares@ $306.01 avg price | Exited |